TARGETING COLD TUMORS USING IPSC-DERIVED CAR T CELLS DIRECTED TO THE IMMUNE CHECKPOINT MOLECULE AND TUMOR-ASSOCIATED ANTIGEN B7-H3JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced FunctionCLINICAL CANCER RESEARCHIF10.22016-07-14315OAAI